university of british columbia

UBC researchers discover key to immune cell's 'internal guidance...

EurekAlert! - Medicine and Health  Sat, 02/04/2012 - 23:00

(University of British Columbia) UBC researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host.The discovery of the role played by the molecule CD74 could help immunologists investigate treatments that offer better immune responses against cancers, viruses and bacteria, and lead to more efficient vaccines.


 

UBC researchers identify potential new therapy approach for hepa...

EurekAlert! - Infectious and Emerging Diseases  Sun, 01/15/2012 - 23:00

(University of British Columbia) Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus in the liver that could lead to new therapies for those affected by this and other infectious diseases.


 

3 research programs win $6M in CIHR grants to promote global hea...

EurekAlert! - Medicine and Health  Mon, 07/25/2011 - 22:00

(University of British Columbia) Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research to promote greater equity in global health.


 

UBC researchers to lead $4.7-million study on early-stage oral c...

EurekAlert! - Cancer  Thu, 05/26/2011 - 22:00

(University of British Columbia) Researchers from the University of British Columbia's Faculties of Medicine, Science and Dentistry are leading a $4.7-million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers.


 

ACTHIV: HIV HAART Therapy Urged for All

MedPage Today Infectious Disease  Fri, 04/08/2011 - 16:36

DENVER (MedPage Today) -- Universal treatment for today's HIV patients is "a real game-changer" that could dramatically slow transmission of the virus and the progress of the pandemic, according to Julio Montaner, MD, of the University of British Columbia in Vancouver.


 

Adverse drug events costly to health care system: Vancouver Coas...

EurekAlert! - Medicine and Health  Thu, 02/24/2011 - 23:00

(University of British Columbia) Patients who suffer an adverse medical event arising from the use or misuse of medications are more costly to the health care system than other emergency department (ED) patients, say physicians and research scientists at Vancouver General Hospital and UBC.

Their research, the first to examine the health outcomes and cost of patient care for patients presenting to the ED with adverse drug events, is published today in the Annals of Emergency Medicine.


 

UBC formulation of leishmaniasis drug shown to be stable, effect...

EurekAlert! - Infectious and Emerging Diseases  Mon, 12/06/2010 - 23:00

(University of British Columbia) A new formulation of Amphotericin B (AmB) developed by University of British Columbia researchers has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.


 

Increased age of sexual consent in Canada may not protect teens ...

EurekAlert! - Medicine and Health  Mon, 11/15/2010 - 23:00

(University of British Columbia) The increase in the legal age of sexual consent from 14 to 16 years in 2008 may not be protecting those at greatest risk, according to researchers who have analyzed British Columbia population-based data and recommend additional strategies to safeguard vulnerable children and teens.


 

Tattooing linked to higher risk of hepatitis C: UBC study

EurekAlert! - Infectious and Emerging Diseases  Thu, 08/05/2010 - 22:00

(University of British Columbia) Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.


 

Updated HIV therapy guidelines would reduce risk of transmission...

EurekAlert! - Medicine and Health  Sun, 06/06/2010 - 22:00

(University of British Columbia) Researchers from the BC Center for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia today released a study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment would create significant benefits for individuals infected with HIV and society.

The mathematical modeling study, published in the research journal PLoS ONE, shows that full implementation of HIV treatment guidelines updated in 2008 by the International AIDS Society (IAS) would lead to more people entering treatment in British Columbia (B.C.).